Literature DB >> 16461841

Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo.

Shoichi Miyamoto1, Teruhisa Kawamura, Tatsuya Morimoto, Koh Ono, Hiromichi Wada, Yosuke Kawase, Akira Matsumori, Ryosuke Nishio, Toru Kita, Koji Hasegawa.   

Abstract

BACKGROUND: Left ventricular (LV) remodeling after myocardial infarction is associated with hypertrophy of surviving myocytes and represents a major process that leads to heart failure. One of the intrinsic histone acetyltransferases, p300, serves as a coactivator of hypertrophy-responsive transcriptional factors such as a cardiac zinc finger protein GATA-4 and is involved in its hypertrophic stimulus-induced acetylation and DNA binding. However, the role of p300-histone acetyltransferase activity in LV remodeling after myocardial infarction in vivo is unknown. METHODS AND
RESULTS: To solve this problem, we have generated transgenic mice overexpressing intact p300 or mutant p300 in the heart. As the result of its 2-amino acid substitution in the p300-histone acetyltransferase domain, this mutant lost its histone acetyltransferase activity and was unable to activate GATA-4-dependent transcription. The two kinds of transgenic mice and the wild-type mice were subjected to myocardial infarction or sham operation at the age of 12 weeks. Intact p300 transgenic mice showed significantly more progressive LV dilation and diminished systolic function after myocardial infarction than wild-type mice, whereas mutant p300 transgenic mice did not show this.
CONCLUSIONS: These findings demonstrate that cardiac overexpression of p300 promotes LV remodeling after myocardial infarction in adult mice in vivo and that histone acetyltransferase activity of p300 is required for these processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461841     DOI: 10.1161/CIRCULATIONAHA.105.585182

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  42 in total

Review 1.  Re-employment of developmental transcription factors in adult heart disease.

Authors:  Toru Oka; Jian Xu; Jeffery D Molkentin
Journal:  Semin Cell Dev Biol       Date:  2006-11-24       Impact factor: 7.727

2.  Kruppel-like factor 15 is a critical regulator of cardiac lipid metabolism.

Authors:  Domenick A Prosdocimo; Priti Anand; Xudong Liao; Han Zhu; Shamanthika Shelkay; Pedro Artero-Calderon; Lilei Zhang; Jacob Kirsh; D'Vesharronne Moore; Mariana G Rosca; Edwin Vazquez; Janos Kerner; Kemal M Akat; Zev Williams; Jihe Zhao; Hisashi Fujioka; Thomas Tuschl; Xiaodong Bai; P Christian Schulze; Charles L Hoppel; Mukesh K Jain; Saptarsi M Haldar
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 3.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 4.  Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease.

Authors:  Miao Cui; Zhaoning Wang; Rhonda Bassel-Duby; Eric N Olson
Journal:  Development       Date:  2018-12-20       Impact factor: 6.868

5.  Decoding the complex genetic causes of heart diseases using systems biology.

Authors:  Djordje Djordjevic; Vinita Deshpande; Tomasz Szczesnik; Andrian Yang; David T Humphreys; Eleni Giannoulatou; Joshua W K Ho
Journal:  Biophys Rev       Date:  2014-12-10

6.  Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy.

Authors:  Roberto Papait; Paola Cattaneo; Paolo Kunderfranco; Carolina Greco; Pierluigi Carullo; Alessandro Guffanti; Valentina Viganò; Giuliano Giuseppe Stirparo; Michael V G Latronico; Gerd Hasenfuss; Ju Chen; Gianluigi Condorelli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-27       Impact factor: 11.205

7.  Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.

Authors:  Yoichi Sunagawa; Tatsuya Morimoto; Tomohide Takaya; Shinji Kaichi; Hiromichi Wada; Teruhisa Kawamura; Masatoshi Fujita; Akira Shimatsu; Toru Kita; Koji Hasegawa
Journal:  J Biol Chem       Date:  2010-01-17       Impact factor: 5.157

8.  The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.

Authors:  Tatsuya Morimoto; Yoichi Sunagawa; Teruhisa Kawamura; Tomohide Takaya; Hiromichi Wada; Atsushi Nagasawa; Masashi Komeda; Masatoshi Fujita; Akira Shimatsu; Toru Kita; Koji Hasegawa
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

9.  Curcumin prevents and reverses murine cardiac hypertrophy.

Authors:  Hong-Liang Li; Chen Liu; Geoffrey de Couto; Maral Ouzounian; Mei Sun; Ai-Bing Wang; Yue Huang; Cheng-Wei He; Yu Shi; Xin Chen; Mai P Nghiem; Youan Liu; Manyin Chen; Fayez Dawood; Masahiro Fukuoka; Yuichiro Maekawa; Liyong Zhang; Andrew Leask; Asish K Ghosh; Lorrie A Kirshenbaum; Peter P Liu
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Currying favor for the heart.

Authors:  Jonathan A Epstein
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.